Get started
Author

Donatienne Van Weehaeghe

Observed names: D Van Weehaeghe, D. Van Weehaeghe, Donatienne van Weehaeghe, Donatienne van de Weehaeghe, Van Weehaeghe, D., Van Weehaeghe, Donatienne, Weehaeghe, Donatienne Van
ORCID: 0000-0001-6646-106X
Observed ORCID: 0000-0001-6646-106X
OpenAlex ID: A5078411722
EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
2021 · Eric Guedj, Andrea Varrone, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 301
PDF
Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease
2020 · Aline Delva, Donatienne Van Weehaeghe, et al. · Movement Disorders · 97
PDF
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents
2022 · Stephen A. Johnson, Ton Fang, et al. · Drugs · 92
18 F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446
2018 · Michel Koole, Mark E. Schmidt, et al. · Journal of Nuclear Medicine · 92
PDF
[11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson’s disease and healthy volunteers
2019 · Donatienne Van Weehaeghe, Michel Koole, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 83
PDF
Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion
2020 · Joke De Vocht, Jeroen Blommaert, et al. · JAMA Neurology · 74
PDF
Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer
2021 · Gwen Schroyen, Jeroen Blommaert, et al. · Cancers · 71
PDF
EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy
2024 · Tatjana Traub-Weidinger, Javier Arbizu, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 60
PDF
TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study
2019 · Donatienne Van Weehaeghe, Evelien Van Schoor, et al. · Journal of Nuclear Medicine · 57
PDF
Prospective Validation of 18 F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis
2016 · Donatienne Van Weehaeghe, Jenny Ceccarini, et al. · Journal of Nuclear Medicine · 55
PDF
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact
2021 · Fabiola De Marchi, Ivana Munitic, et al. · Neuroscience & Biobehavioral Reviews · 53
SNMMI Procedure Standard/EANM Practice Guideline for Brain [ 18 F]FDG PET Imaging, Version 2.0
2024 · Javier Arbizu, Silvia Morbelli, et al. · Journal of Nuclear Medicine · 51
PDF
FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective
2023 · Antoine Verger, Igor Yakushev, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 51
PDF
Regional Accuracy of ZTE-Based Attenuation Correction in Static [18F]FDG and Dynamic [18F]PE2I Brain PET/MR
2019 · Georg Schramm, Michel Koole, et al. · Frontiers in Physics · 50
PDF
Quantification and discriminative power of 18F-FE-PE2I PET in patients with Parkinson’s disease
2019 · Aline Delva, Donatienne Van Weehaeghe, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 38
Direct prospective comparison of 18F-FDG PET and arterial spin labelling MR using simultaneous PET/MR in patients referred for diagnosis of dementia
2020 · Jenny Ceccarini, Sophie Bourgeois, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 37
PDF
2-[18F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee
2022 · Antoine Verger, Henryk Barthel, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 36
PDF
Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands
2020 · Donatienne Van Weehaeghe, Suma Babu, et al. · Journal of Nuclear Medicine · 34
PDF
Clinical validation of the novel HDAC6 radiotracer [18F]EKZ-001 in the human brain
2020 · Michel Koole, Donatienne Van Weehaeghe, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 32
PDF
Combined brain and spinal FDG PET allows differentiation between ALS and ALS mimics
2020 · Donatienne Van Weehaeghe, Martijn Devrome, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 30
Multicenter validation of [18F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls
2018 · Ludovic D’hulst, Donatienne Van Weehaeghe, et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 30
PDF
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0
2025 · Antoine Verger, Nelleke Tolboom, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 29
PDF
Theranostics in Neurooncology: Heading Toward New Horizons
2023 · Nelleke Tolboom, Antoine Verger, et al. · Journal of Nuclear Medicine · 27
PDF
Differences in Cerebral Glucose Metabolism in ALS Patients with and without C9orf72 and SOD1 Mutations
2023 · Joke De Vocht, Donatienne Van Weehaeghe, et al. · Cells · 22
PDF
Regional glucose metabolic decreases with ageing are associated with microstructural white matter changes: a simultaneous PET/MR study
2021 · June van Aalst, Martijn Devrome, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 19
Works count: 93
Citation count: 1,766
H-index: 23
I10-index: 38
Year
Topic
Type